Form 4: Aemetis GC Rockett Boosts Stake with 200K Stock Options

Aemetis, Inc.'s EVP and General Counsel, James Michael Rockett, acquired 200,000 stock options at an exercise price of $2.64, vesting quarterly.

Summary

• James Michael Rockett, Executive Vice President and General Counsel of Aemetis, Inc. (AMTX), was granted 200,000 stock options.
• The options have an exercise price of $2.64 per share.
• The grant date for these options was March 19, 2026.
• The options vest at a rate of 1/12th of the total shares every three months from the grant date.
• The first vesting date is June 19, 2026.
• The options have an expiration date of March 19, 2036.
• Following this transaction, Mr. Rockett beneficially owns 700,000 derivative securities (options).

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal. While not a direct share purchase, the grant of options to a key executive indicates management's belief in the company's future growth and aligns their incentives with shareholder returns.

Positives

• The grant of stock options to a key executive like the EVP and General Counsel can signal management's confidence in the company's future performance.
• This type of compensation aligns the executive's financial interests with those of shareholders, as the options gain value if the stock price increases above the exercise price.

Negatives

• The transaction involves the grant of options, not an outright purchase of common stock, meaning there is no direct cash investment by the insider at this time.
• The exercise of these options in the future could lead to a slight dilution of existing shares, although this is a common aspect of equity compensation plans.

Risks

• The value of the options is contingent on Aemetis, Inc.'s stock price (AMTX) remaining above the $2.64 exercise price; if the stock price falls below this, the options may become worthless.
• General market risks and company-specific operational risks could negatively impact the stock price, affecting the potential value of these options.

Future Outlook

The grant of stock options to a key executive implies an expectation of future stock price appreciation, as the options' value is directly tied to the company's stock performance above the exercise price.

Industry Context

StockSavvy.ai notes that the grant of stock options is a standard practice in executive compensation across various industries, particularly in growth-oriented companies. It serves as a mechanism to incentivize long-term performance and align management's interests with shareholder value creation. This type of insider activity is routinely monitored by investors for signals of management confidence.

Comparison to Industry Standards

• The grant of stock options as a component of executive compensation is a widely adopted practice across industries, including renewable fuels and biochemicals where Aemetis operates.
• The vesting schedule of 1/12th every three months is a common structure designed to retain executives and incentivize sustained performance over several years, comparable to practices at companies like Gevo, Inc. (GEVO) or Renewable Energy Group (REGI, now part of Chevron).

Stakeholder Impact

• Shareholders: May view this as a positive indicator of management confidence and alignment of interests, potentially leading to increased investor sentiment.
• Employees: Standard executive compensation practices can influence overall employee morale and perception of company stability and growth prospects.

Next Steps

• Continued vesting of the granted stock options according to the quarterly schedule, with the first tranche vesting on June 19, 2026.

Key Dates

Keywords

Aemetis, AMTX, stock options, insider transaction, executive compensation, Form 4, James Michael Rockett, General Counsel